Skyrocketing cost of weight-loss drugs has state Medicaid programmes looking for solution

Skyrocketing cost of weight-loss drugs has state Medicaid programmes looking for solution https://www.taxtmi.com/news?id=39952 States facing steep Medicaid spending on GLP 1 weight loss drugs are adopting eligibility and utilization controls to reduce fiscal exposure. Measures include minimum BMI thresholds, requiring trials of diet/exercise or cheaper medications, prior authorization, prescribing limits, step therapy, and restricting coverage to patients with Type 2 diabetes. Some states have rescinded coverage; others seek cost benefit analyses or promote less costly oral agents and nutrition counseling. Policymakers cite potential downstream health savings but note uncertainty about lifelong treatment needs and sustained costs. en-us Sun, 06 Apr 2025 18:46:03 +0530 Sun, 06 Apr 2025 18:46:03 +0530 TaxTMI RSS Generator Skyrocketing cost of weight-loss drugs has state Medicaid programmes looking for solution https://www.taxtmi.com/news?id=39952 States facing steep Medicaid spending on GLP 1 weight loss drugs are adopting eligibility and utilization controls to reduce fiscal exposure. Measures include minimum BMI thresholds, requiring trials of diet/exercise or cheaper medications, prior authorization, prescribing limits, step therapy, and restricting coverage to patients with Type 2 diabetes. Some states have rescinded coverage; others seek cost benefit analyses or promote less costly oral agents and nutrition counseling. Policymakers cite potential downstream health savings but note uncertainty about lifelong treatment needs and sustained costs. News - Sun, 06 Apr 2025 18:46:03 +0530 https://www.taxtmi.com/news?id=39952